Hostname: page-component-cb9f654ff-pvkqz Total loading time: 0 Render date: 2025-09-02T02:46:32.833Z Has data issue: false hasContentIssue false
  • English
  • Français

Disability Adjusted Life Year (DALY) of Central-Line Bloodstream Infection (CLABSI) in a University Hospital in a Developing Country, Brazil

Published online by Cambridge University Press:  16 February 2017

Jaqueline Abel da Rocha ,
Fernanda Moreth do Valle ,
Natalia Chilinque Zambão da Silva ,
Ana Sheila Duarte Nunes Silva ,
Suzana dos Santos Vaz ,
Wildo Navegantes de Araújo  and
Ianick Souto Martins
Jaqueline Abel da Rocha*
Affiliation:
Hospital Universitário Antônio Pedro, School of Medicine of Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil
Fernanda Moreth do Valle
Affiliation:
Hospital Universitário Antônio Pedro, School of Medicine of Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil
Natalia Chilinque Zambão da Silva
Affiliation:
Hospital Universitário Antônio Pedro, School of Medicine of Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil
Ana Sheila Duarte Nunes Silva
Affiliation:
Hospital Universitário Antônio Pedro, School of Medicine of Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil
Suzana dos Santos Vaz
Affiliation:
Hospital Universitário Antônio Pedro, School of Medicine of Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil
Wildo Navegantes de Araújo
Affiliation:
Faculdade UnB Ceilândia, Universidade de Brasília, Brasília-DF, Brazil
Ianick Souto Martins
Affiliation:
Department of Clinical Medicine, School of Medicine of Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.
*
Address correspondence to Jaqueline Abel da Rocha, Rua Marques de Paraná, 303. Niterói, Rio de Janeiro, RJ, CEP 24033-900, Brazil (jaquelineabel@yahoo.com.br).
Get access Rights & Permissions [Opens in a new window]

Abstract

Central-line bloodstream infection (CLABSI) increases hospital mortality. A cohort study was conducted in a Brazilian hospital to estimate the disability-adjusted life year (DALY) of CLABSI using modified World Health Organization (WHO) methodology. CLABSI DALY was 20.44 per 1,000 inpatients, most were the result of premature death (20.42 per 1,000 inpatients). DALY can be useful to guide and measure the impact of healthcare infection prevention.

Infect Control Hosp Epidemiol 2017;38:606–609

Information

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 38 , Issue 5 , May 2017 , pp. 606 - 609
Copyright
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

REFERENCES

1. Rosenthal, VD. Central-line-associated bloodstream infections in limited-resource countries: a review of the literature. Clin Infect Dis 2009;49:1899–1907.CrossRefGoogle ScholarPubMed
2. Rosenthal, VD, Al-Abdely, HM, El-Kholy, AA, et al. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010–2015: device-associated module. Am J Infect Control 2016;44:1495–1504.Google Scholar
3. Murray, CJL, Lopez, AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: The Harvard School of Public Health on behalf of the World Health Organization and The World Bank; 1996.Google Scholar
4. Central line-associated bloodstream infection (CLABSI) event. Device-associated Module CLABSI. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf. Published 2014. Accessed January 31, 2014.Google Scholar
5. Murray, CJ, Ezzati, M, Flaxman, AD, et al. GBD 2010: design, definitions, and metrics. Lancet 2012;380:2063–2066.CrossRefGoogle ScholarPubMed
6. Salomon, JA, Vos, T, Hogan, DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012;380:2129–2143.CrossRefGoogle ScholarPubMed
7. Marlow, MA, Maciel, EL, Sales, CM, et al. Tuberculosis DALY gap: spatial and quantitative comparison of disease burden across urban slum and non-slum census tracts. J Urban Health 2015;92:622–634.CrossRefGoogle ScholarPubMed
8. Cohen, B, Choi, YJ, Hyman, S, Furuya, EY, Neidell, M, Larson, E. Gender differences in risk of bloodstream and surgical site infections. J Gen Intern Med 2013;28:1318–1325.Google Scholar
9. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention website. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Published 2013. Accessed September 02, 2016.Google Scholar
10. Rosenthal, VD, Maki, DG, Rodrigues, C, et al. Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries. Infect Control Hosp Epidemiol 2010;31:1264–1272.Google Scholar